Viva Biotech HoldingsViva Biotech HoldingsViva Biotech Holdings

Viva Biotech Holdings

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪535.40 M‬USD
0.0111USD
‪23.34 M‬USD
‪277.17 M‬USD
‪1.28 B‬
Beta (1Y)
2.51
Employees (FY)
‪2.06 K‬
Change (1Y)
−14 −0.67%
Revenue / Employee (1Y)
‪134.35 K‬USD
Net income / Employee (1Y)
‪11.31 K‬USD

About Viva Biotech Holdings


CEO
Chen Mao
Headquarters
Shanghai
Founded
2008
ISIN
KYG9390W1015
FIGI
BBG00Q8HRQN4
Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. It operates through Drug Discovery, and Contract Development Manufacture Organisation (“CDMO”) and Commercialization segments. The Drug Discovery segment involves in structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage innovative drug development. The Contract Development Manufacture Organisation (“CDMO”) and Commercialization segment consists of contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations. The company was founded by Feng Mao Hua, Chen Cheney Mao and Ying Wu on August 27, 2008 and is headquartered in Shanghai, China.

Check out other big names from the same industry as VBIZF.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of VBIZF is 0.2471 USD — it has decreased by −9.29% in the past 24 hours. Watch Viva Biotech Holdings stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Viva Biotech Holdings stocks are traded under the ticker VBIZF.
VBIZF stock has fallen by −9.15% compared to the previous week, the month change is a −6.26% fall, over the last year Viva Biotech Holdings has showed a 117.52% increase.
We've gathered analysts' opinions on Viva Biotech Holdings future price: according to them, VBIZF price has a max estimate of 0.49 USD and a min estimate of 0.49 USD. Watch VBIZF chart and read a more detailed Viva Biotech Holdings stock forecast: see what analysts think of Viva Biotech Holdings and suggest that you do with its stocks.
VBIZF reached its all-time high on Feb 10, 2021 with the price of 1.8000 USD, and its all-time low was 0.0002 USD and was reached on Jan 20, 2021. View more price dynamics on VBIZF chart.
See other stocks reaching their highest and lowest prices.
VBIZF stock is 10.24% volatile and has beta coefficient of 2.51. Track Viva Biotech Holdings stock price on the chart and check out the list of the most volatile stocks — is Viva Biotech Holdings there?
Today Viva Biotech Holdings has the market capitalization of ‪534.37 M‬, it has decreased by −2.89% over the last week.
Yes, you can track Viva Biotech Holdings financials in yearly and quarterly reports right on TradingView.
Viva Biotech Holdings is going to release the next earnings report on Mar 26, 2026. Keep track of upcoming events with our Earnings Calendar.
VBIZF net income for the last half-year is ‪16.66 M‬ USD, while the previous report showed ‪7.05 M‬ USD of net income which accounts for 136.42% change. Track more Viva Biotech Holdings financial stats to get the full picture.
As of Dec 11, 2025, the company has ‪2.06 K‬ employees. See our rating of the largest employees — is Viva Biotech Holdings on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Viva Biotech Holdings EBITDA is ‪61.63 M‬ USD, and current EBITDA margin is 22.33%. See more stats in Viva Biotech Holdings financial statements.
Like other stocks, VBIZF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Viva Biotech Holdings stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Viva Biotech Holdings technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Viva Biotech Holdings stock shows the buy signal. See more of Viva Biotech Holdings technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.